4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Harmine/AG-CN2-0510-M250/250 mg
商品详细Adipogen/Harmine/AG-CN2-0510-M250/250 mg
Adipogen/Harmine/AG-CN2-0510-M250/250 mg
Adipogen/Harmine/AG-CN2-0510-M250/250 mg
商品编号: AG-CN2-0510-M250
品牌: Adipogen Inc
市场价: ¥3000.00
美元价: 1800.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
Synonyms7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole;BaNISTerine;Leucoharmine;Telepathine;Yageine;BRN0178813
ProductTypeChemical
Properties
FormulaC13H12N2O
MW212.3
CAS442-51-3
RTECSUV0175000
Source/HostChemicalsSynthetic.OriginallyisolatedfromtheseedsofPeganumharmala(Syrianrue).
PurityChemicals≥98%
AppearanceWhiteotoff-whitesolid.
SolubilitySolubleinDMSO.Slightlysolubleinethanol.Insolubleinwater.
OtherProductDataStockSolution:PriortoperformingBIOLOGicalexperimentsthestocksolutionshouldbefurtherdilutedintowaterorotheraqueousbufferstoensurethattheresidualamountofDMSO/ethanolisinsignificant,sinceDMSOandethanolmayhavephysiologicaleffectsathighconcentrations.
Wedonotrecommendtostorethestocksolutionformorethanoneday.
InChiKeyBXNJHAXVSOCGBA-UHFFFAOYSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceKeepcoolanddry.
Protectfromlight.
Protectfrommoistureandoxygen.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Fluorescentβ-carbolinealkaloid.
  • PotentATP-competitiveandselectiveinhibitorofDYRK1A,DYRK2andDYRK3withIC50valuesof0.08,0.9and0.8µM.ShowntoinhibitCLK2,PIM3(at4.3µM)andCK1at1.5µMaswell.InhibitsDYRK1A-mediatedtauphosphorylation.
  • CompetitiveandreversIBLemonoamineoxidaseinhibitor(MAOI)thatreversiblyinhibitsMAO-A(monoamineoxidaseA)buthasnoeffectonMAO-B.
  • Acetylcholinesteraseinhibitor(AChEI).Couldpotentiallyameliorateimpairedmemory.
  • UsefulfluorescentpHindicator.ShowsacolorchangefrompH7.2(bluefluorescence)topH8.9(yellowfluorescence).WiththerADIoisotopecarbon-11,usedinpositronemissiontomographyneuroimagingtoexamineitsbindingtoMAO-A.
  • Antiviralandantileishmanialcompound.
  • Antiangiogenicandantitumoragent.Inhibitscellularproliferation,migration,invasionandinducedapoptosisinvitro,aswellasinhibitedtumorgrowthinvivo.
  • Antidiabetic.UniqueregulatorofPPARγexpressionthatactsbyinhibitingtheWntsignalingpathwayinacell-specificmanner.Inducespancreaticβ-cellproliferation.Reducedbloodglucose,freefattyacidsandtriglyceridelevels,delayedhyperglycemiaandimprovedinsulinsensitivity.
  • ShowntoinduceadipocyteThermogenesisthroughtheRAC1-MEK-ERK-CHD4axis.CHD4directlybindstheproximalpromoterregionofUCP1,servingasanegativemodulatorofUCP1andinducingbrowninginbrown(BAT)andwhiteadiposetissue(WAT).
  • InhibitsDNAtopoisomerasesandinterfereswithDNAsynthesis.InteractswithDNAviabothgroovebindingandintercalativemodesandcausemajorDNAstructuralchanges.
  • Showntopromotedifferentiationofosteoblasts(bone-formingcells)andchondrocytes(cellsinthecartilage)andtoinhibitosteoclastogenesis(theformationofboneresorbingcells).
  • AntimalarialbyinhibitingthePlasmodiumfalciparumheatshockprotein90(PfHSP90)ATP-bindingdomain.
ProductReferences
  1. ThepH-dependenceoftheabsorptionandfluorescencespectraofharmineandharmol:drasticdifferencesinthetautomericequilibriaofgroundandfirstexcitedsingletstate:O.S.Wolfbeis&E.Furlinger;Z.Physik.Chem.129,171(1982)
  2. Antiviraleffectofharmine,aphotoactivebeta-carbolinealkaloid:J.B.Hudson,etal.;Photochem.Photobiol.43,21(1986)
  3. Harmineasasubstitutefor33258HoechstintheFPGtechnique:M.G.Gutierrez-Gonzalvez,etal.;Histochemistry89,199(1988)
  4. EffectofmoclobemideonratbrainmonoamineoxidaseAandB:comparisonwithharmalineandclorgyline:J.Gerardy;Prog.Neuropsychopharmacol.Biol.Psychiatry18,793(1994)
  5. 11C-harmineasatracerformonoamineoxidaseA(MAO-A):invitroandinvivostudies:M.Bergstrom,etal.;Nucl.Med.Biol.24,287(1997)
  6. Antitumoragents201.Cytotoxicityofharmineandbeta-carbolineanalogs:J.Ishida,etal.;Bioorg.Med.Chem.Lett.9,3319(1999)
  7. Harmine:evaluationofitsantileishmanialpropertiesinvariousvesiculardeliverysystems:S.Lala,etal.;J.DrugTarget12,165(2004)
  8. Thesmallmoleculeharmineisanantidiabeticcell-type-specificregulatorofPPARgammaexpression:H.Waki,etal.;CellMetab.5,357(2007)
  9. Theselectivityofproteinkinaseinhibitors:afurtherupdate:J.Bain,etal.;Biochem.J.408,297(2007)
  10. DYRK1Aphosphorylatescaspase9ataninhibitorysiteandispotentlyinhibitedinhumancellsbyharmine:A.Seifert,etal.;FEBSJ.275,6268(2008)
  11. HarminespecificallyinhibitsproteinkinaseDYRK1Aandinterfereswithneuriteformation:N.Gockler,etal.;FEBSJ.276,6324(2009)
  12. β-CarbolinealkaloidsbindDNA:S.Nafisi,etal.;J.Photochem.Photobiol.B:Biol.100,84(2010)
  13. Harmine,aβ-carbolinealkaloid,inhibitsosteoclastdifferentiationandboneresorptioninvitroandinvivo:T.Yonezawa,etal.;Eur.J.Pharmacol.650,511(2011)
  14. HarmineisanATP-competitiveinhibitorfordual-specificitytyrosinephosphorylation-regulatedkinase1A(Dyrk1A):T.Adayev,etal.;Arch.Biochem.Biophys.507,212(2011)
  15. ThesmallmoleculeharmineregulatesNFATc1andId2expressioninosteoclastProgenitorcells:H.Egusa,etal.;Bone49,264(2011)
  16. β-carbolinecompounds,includingharmine,inhibitDYRK1AandtauphosphorylationatmultipleAlzheimer"sdisease-relatedsites:D.Frost,etal.;PLoSOne6,e19264(2011)
  17. HarmineisapotentantimalarialtargetingHsp90andsynergizeswithchloroquineandartemisinin:D.Shahinas,etal.;Antimicrob.AgentsChemother.56,4207(2012)
  18. Harmineinducesapoptosisandinhibitstumorcellproliferation,migrationandinvasionthroughdown-regulationofcyclooxygenase-2expressioningastriccancer:H.Zhang,etal.;Phytomedicine21,348(2014)
  19. Ahigh-throughputchemicalscreenrevealsthatharmine-mediatedinhibitionofDYRK1Aincreaseshumanpancreaticbetacellreplication:P.Wang,etal.;Nat.Med.21,383(2015)
  20. Effectsofharmine,anacetylcholinesteraseinhibitor,onspatiallearningandmemoryofAPP/PS1transgenicmiceandscopolamine-inducedmemoryimpairmentmice:D.He,etal.;Eur.J.Pharmacol.768,96(2015)
  21. Selectivityprofilingandbiologicalactivityofnovelβ-carbolinesaspotentandselectiveDYRK1kinaseinhibitors:K.Ruben,etal.;PLosOne10,e0132453(2015)
  22. Harmineinducescellcyclearrestandmitochondrialpathway-mediatedcellularapoptosisinSW620cellsviainhibitionoftheAktandERKsignalingpathways:J.Liu,etal.;Oncol.Rep.35,3363(2016)
  23. HarmineInducesAdipocyteThermogenesisthroughRAC1-MEK-ERK-CHD4Axis:T.Nie,etal.;Sci.Rep.6,36382(2016)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。